Header cover image

U.K. (FTSE) Healthcare Sector Analysis

UpdatedNov 28, 2022
DataAggregated Company Financials
Companies119
  • 7D0.7%
  • 3M-2.1%
  • 1Y1.0%
  • YTD-1.1%

Over the last 7 days, the Healthcare industry has remained flat, although notably Abcam declined by 4.9%. Furthermore, the industry has been flat for the past year as well. Earnings are forecast to grow by 23% annually.

Sector Valuation and Performance

Has the U.K. Healthcare Sector valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Mon, 28 Nov 2022UK£275.4bUK£95.2bUK£6.6b38.1x41.6x2.9x
Wed, 26 Oct 2022UK£252.9bUK£95.3bUK£4.0b29.2x63.1x2.7x
Fri, 23 Sep 2022UK£252.9bUK£96.3bUK£4.0b32.4x63.1x2.6x
Sun, 21 Aug 2022UK£282.8bUK£93.8bUK£4.0b35.7x70x3x
Tue, 19 Jul 2022UK£308.9bUK£90.6bUK£4.9b34.1x62.8x3.4x
Thu, 16 Jun 2022UK£288.3bUK£89.7bUK£5.0b28.6x58x3.2x
Sat, 14 May 2022UK£298.0bUK£89.0bUK£5.0b28.3x59.7x3.3x
Mon, 11 Apr 2022UK£316.3bUK£81.3bUK£5.1b35.4x61.8x3.9x
Wed, 09 Mar 2022UK£265.3bUK£81.0bUK£5.1b29.8x52.2x3.3x
Fri, 04 Feb 2022UK£271.1bUK£75.1bUK£6.0b31.5x45.1x3.6x
Sun, 02 Jan 2022UK£285.0bUK£75.3bUK£6.0b32.4x47.2x3.8x
Tue, 30 Nov 2021UK£273.6bUK£75.9bUK£6.1b29.7x45x3.6x
Thu, 28 Oct 2021UK£281.6bUK£72.0bUK£7.8b30.2x36x3.9x
Sat, 25 Sep 2021UK£273.6bUK£71.9bUK£8.0b33.9x34.3x3.8x
Mon, 23 Aug 2021UK£276.7bUK£71.4bUK£7.9b32.8x35.3x3.9x
Sat, 10 Jul 2021UK£251.2bUK£71.2bUK£7.8b37.9x32.2x3.5x
Fri, 02 Apr 2021UK£217.4bUK£68.8bUK£8.7b33x25x3.2x
Mon, 04 Jan 2021UK£219.9bUK£69.8bUK£8.1b43.6x27.1x3.2x
Thu, 08 Oct 2020UK£235.8bUK£70.4bUK£8.3b41.2x28.6x3.3x
Wed, 01 Jul 2020UK£241.2bUK£72.2bUK£8.6b36.4x28.2x3.3x
Sat, 04 Apr 2020UK£213.3bUK£72.1bUK£7.1b33.1x30.1x3x
Tue, 07 Jan 2020UK£239.2bUK£68.4bUK£6.6b35.3x36.1x3.5x
Price to Earnings Ratio

31x


Total Market Cap: UK£233.7bTotal Earnings: UK£7.5bTotal Revenue: UK£69.3bTotal Market Cap vs Earnings and Revenue0%0%0%
U.K. Healthcare Sector Price to Earnings3Y Average 41.7x202020212022
Current Industry PE
  • Investors are relatively neutral on the British Healthcare industry at the moment, indicating that they anticipate long term growth rates to remain steady.
  • The industry is trading close to its 3-year average PE ratio of 41.7x.
  • The 3-year average PS ratio of 3.4x is higher than the industry's current PS ratio of 2.9x.
Past Earnings Growth
  • The earnings for companies in the Healthcare industry have declined 4.3% per year over the last three years.
  • Meanwhile revenues for these companies have grown 11% per year.
  • This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has decreased profits.

Industry Trends

Which industries have driven the changes within the U.K. Healthcare sector?

GB Market1.33%
Healthcare0.72%
Medical Equipment2.02%
Healthcare Services1.00%
Healthtech0.76%
Pharma0.70%
Biotech-0.57%
Life Sciences-1.42%
Industry PE
  • Investors are most optimistic about the Medical Equipment industry, which is trading close to its 3-year average PE ratio of 49.8x.
    • Analysts are expecting annual earnings growth of 21.8%, which is higher than its past year's earnings decline of 43.4% per year.
Forecasted Growth
  • Analysts are most optimistic on the Biotech industry, expecting annual earnings growth of 24% over the next 5 years.
  • This is better than its past earnings decline of 34% per year.
  • In contrast, the Healthcare Services industry is expected to see its earnings grow by 18% per year over the next few years.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
GSK GSKUK£13.921.8%
+UK£971.6m
-26.3%PE12.7x
AZN AstraZenecaUK£109.540.3%
+UK£526.8m
30.2%PE100.6x
SN. Smith & NephewUK£11.043.3%
+UK£308.7m
-10.6%PE23.4x
HIK Hikma PharmaceuticalsUK£15.236.6%
+UK£207.0m
-33.1%PE11.7x
PRTC PureTech HealthUK£2.7213.1%
+UK£87.7m
-12.4%PS49.2x
Simply Wall St™
Simply Wall Street Pty Ltd
17-21 Bellevue Street, Surry Hills, Sydney
Download on the App StoreGet it on Google Play
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

AZN

UK£109.54

AstraZeneca

7D

0.3%

1Y

30.2%

APH

UK£0.43

Alliance Pharma

7D

-27.3%

1Y

-57.3%

ERGO

UK£13.02

Ergomed

7D

-2.4%

1Y

-2.1%

DPH

UK£27.62

Dechra Pharmaceuticals

7D

1.2%

1Y

-45.4%

SCLP

UK£0.23

Scancell Holdings

7D

26.1%

1Y

9.4%

HCM

UK£1.80

HUTCHMED (China)

7D

-2.3%

1Y

-66.2%

GSK

UK£13.92

GSK

7D

1.8%

1Y

-26.3%

AVCT

UK£1.10

Avacta Group

7D

-6.0%

1Y

-8.3%

HIK

UK£15.23

Hikma Pharmaceuticals

7D

6.6%

1Y

-33.1%

FARN

UK£2.25

Faron Pharmaceuticals Oy

7D

-9.1%

1Y

-27.4%

ABC

UK£13.20

Abcam

7D

-4.9%

1Y

-21.8%

PRTC

UK£2.72

PureTech Health

7D

13.1%

1Y

-12.4%